Chemotherapy-based versus chemotherapy-free stem cell mobilization (± plerixafor) in multiple myeloma patients: an Italian cost-effectiveness analysis

1.Alegre A, Tomas JF, Martinez-Chamorro C, Gil-Fernandez JJ, Fernandez-Villalta MJ, Arranz R, et al. Comparison of peripheral blood progenitor cell mobilization in patients with multiple myeloma: high-dose cyclophosphamide plus GM-CSF vs G-CSF alone. Bone Marrow Transpl. 1997;20:211–7. https://doi.org/10.1038/sj.bmt.1700867. e-pub ahead of print 1997/08/01CAS  Article  Google Scholar  2.Goldschmidt H, Hegenbart U, Wallmeier M, Hohaus S, Haas [...]

Published March 21, 2021 at 07:48PM. Read full article at Stem Cells in the News Portal.